表紙
市場調査レポート

神経因性疼痛:世界の治験レビュー

Neuropathic Pain Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 167075
出版日 ページ情報 英文 178 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
神経因性疼痛:世界の治験レビュー Neuropathic Pain Global Clinical Trials Review, H1, 2014
出版日: 2014年06月20日 ページ情報: 英文 178 Pages
概要

当レポートでは、世界の主要地域おける神経因性疼痛治療薬の治験数や被験者数、段階別の動向、主要企業や機関、治験のプロファイルなどをまとめています。

イントロダクション

  • 神経因性疼痛
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域上位5ヶ国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する神経因性疼痛の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験件数に対する神経因性疼痛の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

神経因性疼痛の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Pfizer Inc.
    • AstraZeneca PLC
    • Grunenthal GmbH
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • NeurogesX, Inc.
    • GW Pharmaceuticals plc
    • Spinifex Pharmaceuticals Pty Limited
    • Endo International plc
    • AbbVie Inc.
  • 代表的な研究機関・病院の治験の概要
    • UNIVERSITY HOSPITAL, CLERMONT-FERRAND
    • Lawson Health Research Institute
    • Rigshospitalet
    • Leiden University Medical Center
    • Danish Pain Research Center
    • Rambam Health Care Campus
    • University of Manitoba
    • University of California, San Francisco
    • U.S. Department of Veterans Affairs
    • Capital District Health Authority, Canada

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2217CTIDB

GlobalData's clinical trial report, "Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathic Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuropathic Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Neuropathic Pain
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Neuropathic Pain
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Neuropathic Pain Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Neuropathic Pain
    • May 05, 2014: Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Grunenthal GmbH
      • Clinical Trial Overview of Grunenthal GmbH
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • NeurogesX, Inc.
      • Clinical Trial Overview of NeurogesX, Inc.
      • GW Pharmaceuticals plc
      • Clinical Trial Overview of GW Pharmaceuticals plc
      • Spinifex Pharmaceuticals Pty Limited
      • Clinical Trial Overview of Spinifex Pharmaceuticals Pty Limited
      • Endo International plc
      • Clinical Trial Overview of Endo International plc
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • UNIVERSITY HOSPITAL, CLERMONT-FERRAND
      • Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Danish Pain Research Center
      • Clinical Trial Overview of Danish Pain Research Center
      • Rambam Health Care Campus
      • Clinical Trial Overview of Rambam Health Care Campus
      • University of Manitoba
      • Clinical Trial Overview of University of Manitoba
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Capital District Health Authority, Canada
      • Clinical Trial Overview of Capital District Health Authority, Canada
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Neuropathic Pain Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Neuropathic Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Neuropathic Pain Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Spinifex Pharmaceuticals Pty Limited, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by UNIVERSITY HOSPITAL, CLERMONT-FERRAND, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Pain Research Center, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014*

List of Figures

  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top